Rhode Island 2022 Regular Session

Rhode Island House Bill H7131

Introduced
1/20/22  

Caption

Opioid Alternatives

Impact

The key provisions of the bill require health care practitioners to inform patients about available opioid alternatives, discuss the advantages and disadvantages of these alternatives, and distribute the educational pamphlet to patients. It also stipulates that pharmacies must display a list of the most prescribed opioids along with warnings related to their use, which could significantly enhance awareness and potentially reduce prescription opioid usage among patients. This aims to encourage both practitioners and patients to consider safer, less addictive alternatives for pain relief.

Summary

House Bill 7131 aims to provide Rhode Island residents with more information about non-opioid alternatives for pain management. The bill mandates the Department of Health to develop an educational pamphlet that outlines various non-opioid treatments and emphasizes the right of competent adults to make informed decisions regarding their health care, particularly concerning the use of Schedule II controlled substances. It recognizes the need for alternative pain relief methods amidst the ongoing opioid crisis that has affected many individuals and families across the state.

Contention

While the bill is largely seen as a proactive measure, it may face contention regarding the practical implementation of these regulations. Concerns may arise over the educational requirements placed on health care practitioners, as well as the effectiveness of the pamphlets in truly informing patients about alternatives. Additionally, some stakeholders in the medical community may argue the importance of prescribing opioids in specific cases and the need for a balanced approach to pain management that recognizes the necessity of opioids under certain conditions.

Companion Bills

No companion bills found.

Similar Bills

NJ A3342

Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven day supply, except in certain circumstances.

NJ A2191

Increases amount allowed in initial prescription for opioid drugs in cases of acute pain.

CA AB1998

Opioids: safe prescribing policy.

NJ A2260

Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.

NJ A3630

Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.

TX HB2174

Relating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.

NJ A2731

Expands prescription monitoring program to include veterinarians.

CT SB00511

An Act Concerning Opioids.